Clinical Trial Update: FMP2.1/AS02A: Rabies Vaccine Malaria-Experienced Adults in Bandiagara, Mali [Phase 1]

View source ↗

Summary

Phase 1 trial update for the malaria vaccine FMP2.1/AS02A in malaria-experienced adults in Mali; the study is completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria
• Plasmodium Falciparum Malaria

Drugs mentioned

• FMP2.1/AS02A

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Malaria, Plasmodium Falciparum Malaria | Phase 1 | Status: COMPLETED | Results posted: 2017-07-24